We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Reviewers Question Safety, Efficacy of Amgen’s Aranesp
FDA Reviewers Question Safety, Efficacy of Amgen’s Aranesp
October 15, 2010
FDA reviewers in a report released Thursday express doubt that Amgen’s Aranesp is a safe and effective treatment to raise hemoglobin levels in patients with anemia caused by chronic kidney disease (CKD).